Skip to main content
Top

Open Access 25-04-2024 | Congenital Heart Anomaly | Review

Duct Stenting in Duct-Dependent Systemic Blood Flow, Past, Present, and Future

Author: Dietmar Schranz

Published in: Pediatric Cardiology

Login to get access

Abstract

Arterial duct stenting, pioneered in the early 1990s for newborns with a duct-dependent pulmonary and systemic circulation, has evolved significantly over the past decades. This progressive technique has led to the development of novel therapeutic strategies, including the Hybrid approach introduced three decades ago, and more recently, a complete transcatheter approach for treating newborns with hypoplastic left heart syndrome (HLHS). Subsequently, the transcatheter method has been extended to bi-ventricular lesions and patients with pulmonary hypertension, establishing a reverse Potts-shunt pathophysiology. Considering current experiences, this review aims to assess the strengths, weaknesses, and complications associated with ductal stenting, which represents a critical component of these complex treatment strategies. Despite advancements, the mortality rate of Norwood and Hybrid stage-1 procedures has plateaued, underscoring the importance of enhancing the quality of life of affected patients as the primary therapeutic goal. The prerequisite is a gentle, almost atraumatic medicine, particularly during the newborn period. It is essential to recognize that both the Hybrid and total transcatheter approaches demand comparable experience to Norwood surgery. Successful outcomes hinge on much more than merely inserting a stent into the duct; they require meticulous attention to detail and comprehensive management strategies.
Literature
1.
go back to reference Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316(12):701–706CrossRefPubMed Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316(12):701–706CrossRefPubMed
2.
go back to reference Ruiz CE, Gamra H, Zhang HP, Boucek MM (1993) Brief report: stenting of the ductus arteriosus as a bridge to cardiac transplantation in infants with the hypoplastic left-heart syndrome. N Engl J Med 328(22):1605–1608CrossRefPubMed Ruiz CE, Gamra H, Zhang HP, Boucek MM (1993) Brief report: stenting of the ductus arteriosus as a bridge to cardiac transplantation in infants with the hypoplastic left-heart syndrome. N Engl J Med 328(22):1605–1608CrossRefPubMed
3.
go back to reference Gibbs JL, Wren C, Watterson KG, Hunter S, Hamilton JR (1993) Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome. Br Heart J 69(6):551–555CrossRefPubMedPubMedCentral Gibbs JL, Wren C, Watterson KG, Hunter S, Hamilton JR (1993) Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome. Br Heart J 69(6):551–555CrossRefPubMedPubMedCentral
4.
go back to reference Gibbs JL, Uzon D, Blackburn MEC (1999) Fate of the stented arterial duct. 8HLHS and 10Pat. Ductal stenting cannot be recommend- ed. Circulation 99:2621–2625CrossRefPubMed Gibbs JL, Uzon D, Blackburn MEC (1999) Fate of the stented arterial duct. 8HLHS and 10Pat. Ductal stenting cannot be recommend- ed. Circulation 99:2621–2625CrossRefPubMed
5.
go back to reference Michelbehnke I, Akintürk H, Schranz D (2000) Fate of the stented arterial duct. Circulation 102:e178PubMed Michelbehnke I, Akintürk H, Schranz D (2000) Fate of the stented arterial duct. Circulation 102:e178PubMed
6.
go back to reference Dapper F, Bauer J, Kroll J, Zickmann B, Bohle RM, Hagel KJ, Schranz D (1998) Clinical experience with heart transplantation in infants. Eur J Cardiothorac Surg 14(1):1–5CrossRefPubMed Dapper F, Bauer J, Kroll J, Zickmann B, Bohle RM, Hagel KJ, Schranz D (1998) Clinical experience with heart transplantation in infants. Eur J Cardiothorac Surg 14(1):1–5CrossRefPubMed
7.
go back to reference Akintuerk H, Michel-Behnke I, Valeske K, Mueller M, Thul J, Bauer J, Hagel KJ, Kreuder J, Schranz D (2002) Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation 105(9):1099–1103CrossRefPubMed Akintuerk H, Michel-Behnke I, Valeske K, Mueller M, Thul J, Bauer J, Hagel KJ, Kreuder J, Schranz D (2002) Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation 105(9):1099–1103CrossRefPubMed
8.
go back to reference Akintuerk H, Michel-Behnke I, Valeske K, Mueller M, Thul J, Bauer J, Hagel KJ, Schranz D (2007) Hybrid transcatheter-surgical palliation: basis for univentricular or biventricular repair: the Giessen experience. Pediatr Cardiol 28(2):79–87CrossRef Akintuerk H, Michel-Behnke I, Valeske K, Mueller M, Thul J, Bauer J, Hagel KJ, Schranz D (2007) Hybrid transcatheter-surgical palliation: basis for univentricular or biventricular repair: the Giessen experience. Pediatr Cardiol 28(2):79–87CrossRef
9.
go back to reference Schranz D, Bauer A, Reich B, Steinbrenner B, Recla S, Schmidt D et al (2015) Fifteen-year single center experience with the “Giessen Hybrid” approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol 36:365–373CrossRefPubMed Schranz D, Bauer A, Reich B, Steinbrenner B, Recla S, Schmidt D et al (2015) Fifteen-year single center experience with the “Giessen Hybrid” approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol 36:365–373CrossRefPubMed
10.
go back to reference Galantowicz M, Cheatham JP (2005) Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol 26(3):190–199CrossRefPubMed Galantowicz M, Cheatham JP (2005) Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol 26(3):190–199CrossRefPubMed
11.
go back to reference Galantowicz M, Cheatham JP, Phillips A, Cua CL, Hoffman TM, Hill SL et al (2008) Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg 85:2063–2070CrossRefPubMed Galantowicz M, Cheatham JP, Phillips A, Cua CL, Hoffman TM, Hill SL et al (2008) Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg 85:2063–2070CrossRefPubMed
12.
go back to reference Ohye RG, Schranz D, Dudekem Y (2016) Current therapy for hypoplastic left heart syndrome and related single ventricle lesions. Circulation 134(17):1265–1279CrossRefPubMedPubMedCentral Ohye RG, Schranz D, Dudekem Y (2016) Current therapy for hypoplastic left heart syndrome and related single ventricle lesions. Circulation 134(17):1265–1279CrossRefPubMedPubMedCentral
14.
go back to reference Akintürk H, Yörüker U, Schranz D (2022) Hypoplastic left heart syndrome palliation: technical aspects and common pitfalls of the hybrid approach. World J Pediatr Congenit Heart Surg 13(5):588–592CrossRefPubMed Akintürk H, Yörüker U, Schranz D (2022) Hypoplastic left heart syndrome palliation: technical aspects and common pitfalls of the hybrid approach. World J Pediatr Congenit Heart Surg 13(5):588–592CrossRefPubMed
15.
go back to reference Miller-Tate H, Fichtner S, Davis JA, Alvarado C, Conroy S, Bigelow AM, Wright L, Galantowicz M, Cua CL (2023) Utility of the NEONATE score at an institution that routinely performs the hybrid procedure for hypoplastic left heart syndrome. Pediatr Cardiol 44(8):1684–1690CrossRefPubMed Miller-Tate H, Fichtner S, Davis JA, Alvarado C, Conroy S, Bigelow AM, Wright L, Galantowicz M, Cua CL (2023) Utility of the NEONATE score at an institution that routinely performs the hybrid procedure for hypoplastic left heart syndrome. Pediatr Cardiol 44(8):1684–1690CrossRefPubMed
16.
17.
go back to reference Yerebakan C, Valeske K, Elmontaser H, Yörüker U, Mueller M, Thul J, Mann V, Latus H, Villanueva A, Hofmann K, Schranz D, Akintuerk H (2016) Hybrid therapy for hypoplastic left heart syndrome – Myth, alternative or standard? J Thorac Cardiovasc Surg 151:1112–1121CrossRefPubMed Yerebakan C, Valeske K, Elmontaser H, Yörüker U, Mueller M, Thul J, Mann V, Latus H, Villanueva A, Hofmann K, Schranz D, Akintuerk H (2016) Hybrid therapy for hypoplastic left heart syndrome – Myth, alternative or standard? J Thorac Cardiovasc Surg 151:1112–1121CrossRefPubMed
18.
go back to reference Michel-Behnke I, Akintuerk H, Marquardt I, Mueller M, Thul J, Bauer J, Hagel KJ, Kreuder J, Vogt P, Schranz D (2003) Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart 89(6):645–650CrossRefPubMedPubMedCentral Michel-Behnke I, Akintuerk H, Marquardt I, Mueller M, Thul J, Bauer J, Hagel KJ, Kreuder J, Vogt P, Schranz D (2003) Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart 89(6):645–650CrossRefPubMedPubMedCentral
19.
go back to reference Yerebakan C, Murray J, Valeske K, Thul J, Elmontaser H, Mueller M et al (2015) Long-term results of biventricular repair after initial Giessen hybrid approach for hypoplastic left heart variants. J Thorac Cardiovasc Surg 149(4):1112–1120CrossRefPubMed Yerebakan C, Murray J, Valeske K, Thul J, Elmontaser H, Mueller M et al (2015) Long-term results of biventricular repair after initial Giessen hybrid approach for hypoplastic left heart variants. J Thorac Cardiovasc Surg 149(4):1112–1120CrossRefPubMed
20.
go back to reference Argo MB, Barron DJ, Eghtesady P, Yerebakan C, DeCampli WM, Alsoufi B, Honjo O, Jacobs JP, Paramananthan T, Rahman M, Lambert LM, Jegatheeswaran A, Carrillo SA, Husain SA, Ramakrishnan K, Caldarone CA, Karamlou T, Nelson J, Mannie C, Romano JC, Turek JW, Blackstone EH, Galantowicz ME, Kirklin JK, Mitchell ME, McCrindle BW (2023) Congenital Heart Surgeons Society Critical Left Heart Obstruction Work Group. Outcomes after hybrid palliation for infants with critical left Heart Obstruction. J Am Coll Cardiol 82(14):1427–1441CrossRefPubMed Argo MB, Barron DJ, Eghtesady P, Yerebakan C, DeCampli WM, Alsoufi B, Honjo O, Jacobs JP, Paramananthan T, Rahman M, Lambert LM, Jegatheeswaran A, Carrillo SA, Husain SA, Ramakrishnan K, Caldarone CA, Karamlou T, Nelson J, Mannie C, Romano JC, Turek JW, Blackstone EH, Galantowicz ME, Kirklin JK, Mitchell ME, McCrindle BW (2023) Congenital Heart Surgeons Society Critical Left Heart Obstruction Work Group. Outcomes after hybrid palliation for infants with critical left Heart Obstruction. J Am Coll Cardiol 82(14):1427–1441CrossRefPubMed
21.
go back to reference Feltes TF, Bacha E, Beekman RH 3rd et al (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Asso- ciation. Circulation 123:2607–2652CrossRefPubMed Feltes TF, Bacha E, Beekman RH 3rd et al (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Asso- ciation. Circulation 123:2607–2652CrossRefPubMed
22.
go back to reference Schranz D, Voelkel NF (2016) “Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 175(4):445–455CrossRefPubMedPubMedCentral Schranz D, Voelkel NF (2016) “Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 175(4):445–455CrossRefPubMedPubMedCentral
23.
go back to reference Mienert T, Esmaeili A, Steinbrenner B, Khalil M, Müller M, Akintuerk H, Kerst G, Schranz D (2021) Cardiovascular drug therapy during interstage after hybrid approach: a single-center experience in 51 newborns with hypoplastic left heart. Paediatr Drugs 23(2):195–202CrossRefPubMedPubMedCentral Mienert T, Esmaeili A, Steinbrenner B, Khalil M, Müller M, Akintuerk H, Kerst G, Schranz D (2021) Cardiovascular drug therapy during interstage after hybrid approach: a single-center experience in 51 newborns with hypoplastic left heart. Paediatr Drugs 23(2):195–202CrossRefPubMedPubMedCentral
24.
go back to reference Schranz D, Akintuerk H, Voelkel NF (2017) ‘End-stage’ heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation. Heart 103(4):262–267CrossRefPubMed Schranz D, Akintuerk H, Voelkel NF (2017) ‘End-stage’ heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation. Heart 103(4):262–267CrossRefPubMed
25.
go back to reference Schranz D, Akintuerk H, Esmaeili A, Latus H, Apitz C (2021) Heart failure therapy based on interventricular mechanics and cardio-vascular communications. Cardiovasc Diagn Ther 11(4):1080–1088CrossRefPubMedPubMedCentral Schranz D, Akintuerk H, Esmaeili A, Latus H, Apitz C (2021) Heart failure therapy based on interventricular mechanics and cardio-vascular communications. Cardiovasc Diagn Ther 11(4):1080–1088CrossRefPubMedPubMedCentral
26.
go back to reference Schranz D (2021) Reverse Potts shunt for pulmonary hypertension: back to a “fetal” circulation in part? J Am Coll Cardiol 78(5):478–480CrossRefPubMed Schranz D (2021) Reverse Potts shunt for pulmonary hypertension: back to a “fetal” circulation in part? J Am Coll Cardiol 78(5):478–480CrossRefPubMed
27.
go back to reference Latus H, Apitz C, Moysich A, Kerst G, Jux C, Bauer J, Schranz D (2014) Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies. J Heart Lung Transplant 33(5):542–546CrossRefPubMed Latus H, Apitz C, Moysich A, Kerst G, Jux C, Bauer J, Schranz D (2014) Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies. J Heart Lung Transplant 33(5):542–546CrossRefPubMed
28.
go back to reference Blanc J, Vouhe P, Bonnet D (2004) Potts shunt in patients with pulmonary hypertension. N Engl J Med 350:623CrossRefPubMed Blanc J, Vouhe P, Bonnet D (2004) Potts shunt in patients with pulmonary hypertension. N Engl J Med 350:623CrossRefPubMed
29.
go back to reference Baruteau AE, Belli E, Boudjemline Y et al (2015) Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients. Eur J Cardiothorac Surg 47:e105–e110CrossRefPubMed Baruteau AE, Belli E, Boudjemline Y et al (2015) Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients. Eur J Cardiothorac Surg 47:e105–e110CrossRefPubMed
30.
go back to reference Schranz D, Kerst G, Menges T, Akintürk H, van Alversleben I, Ostermayer S, Apitz C, Moysich A (2015) Transcatheter creation of a reverse Potts shunt in a patient with severe pulmonary arterial hypertension associated with Moyamoya syndrome. EuroIntervention 11(1):121CrossRefPubMed Schranz D, Kerst G, Menges T, Akintürk H, van Alversleben I, Ostermayer S, Apitz C, Moysich A (2015) Transcatheter creation of a reverse Potts shunt in a patient with severe pulmonary arterial hypertension associated with Moyamoya syndrome. EuroIntervention 11(1):121CrossRefPubMed
31.
37.
go back to reference Kurtz JD, Alsoufi B, Wilkens SJ, Kim E (2021) Modified microvascular plug as a flow restrictor in hypoplastic left heart syndrome with dysplastic tricuspid and pulmonary valves. Pediatr Cardiol 42(7):1653–1657CrossRefPubMed Kurtz JD, Alsoufi B, Wilkens SJ, Kim E (2021) Modified microvascular plug as a flow restrictor in hypoplastic left heart syndrome with dysplastic tricuspid and pulmonary valves. Pediatr Cardiol 42(7):1653–1657CrossRefPubMed
38.
go back to reference Kiene AM, Waller BR 3rd, Knott-Craig C, Sathanandam SK (2021) Percutaneous stage 1 palliation for hypoplastic left heart syndrome. Ann Thorac Surg 112(5):e341–e343CrossRefPubMed Kiene AM, Waller BR 3rd, Knott-Craig C, Sathanandam SK (2021) Percutaneous stage 1 palliation for hypoplastic left heart syndrome. Ann Thorac Surg 112(5):e341–e343CrossRefPubMed
Metadata
Title
Duct Stenting in Duct-Dependent Systemic Blood Flow, Past, Present, and Future
Author
Dietmar Schranz
Publication date
25-04-2024
Publisher
Springer US
Published in
Pediatric Cardiology
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-024-03492-y
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine